A Mechanistic Model of Ehlers-Danlos Syndrome, Mast Cell Activation Syndrome, and Postural Orthostatic Tachycardia Syndrome
A Vicious Cycle of Mitochondrial Dysfunction and Systemic Dysregulation
Ehlers-Danlos Syndrome (EDS), Mast Cell Activation Syndrome (MCAS), and Postural Orthostatic Tachycardia Syndrome (POTS) frequently present as a clinical triad, suggesting shared pathophysiological mechanisms. This essay proposes a comprehensive model wherein environmental stressors trigger mitochondrial dysfunction, initiating a cascade of interconnected failures involving heme synthesis disruption, exclusion zone (EZ) water depletion, metabolic shifts, collagen breakdown, barrier integrity disruption, immune activation, nervous system dysregulation, and autonomic dysregulation.
Each mechanism is interconnected, forming a self-reinforcing cycle that perpetuates chronic symptoms of EDS (hypermobility, tissue fragility), MCAS (hypersensitivity, inflammation), and POTS (orthostatic intolerance, fatigue). Below, each step is detailed to provide clinicians with a mechanistic framework for understanding and potentially addressing these syndromes.
A Vicious Cycle of Interconnected Mechanisms
Environmental Stressors Fuel the Cycle: Blue light, non-native EMFs, environmental toxins, vaccines, and LNPs damage cyctochrome c oxidase and and the inner mitochondrial membrane (IMM), continuously impeding mitochondrial function, initiating and sustaining a vicious cycle.
Note: Please refer to the Addendum on Environmental Stressors for a comprehensive explanation of the mechanisms behind their effects
Interlinked Mechanisms Amplify Each Other:
IMM damage leads to porphyrin accumulation heightening blue light sensitivity and Fenton reactions lead to increased ROS, including hydroxyl radicals, amplifying membrane damage.
Impaired proton flow and disrupted bioelectric signaling (due to mitochondrial dysfunction) reduce cellular communication and stability.
EZ water depletion, often worsened by dehydration, weakens cellular, barrier, and tissue integrity, exacerbating instability (EDS) and triggering histamine release as a drought management response.[30]
Barrier permeability in the gut, blood-brain barrier, and vascular endothelium allows toxin infiltration, triggering inflammation.
Inflammation and mast cell activation (MCAS), amplified by dehydration-induced histamine elevation, release mediators that degrade collagen, worsening tissue instability.
Tissue instability activates sympathetic overdrive, increasing ROS and further impairing mitochondrial function.
Sympathetic hyperactivity and autonomic dysregulation (POTS) sustain inflammation, perpetuating the cycle.
Resulting Manifestations: This interconnected cycle drives chronic, multisystem symptoms:
EDS: Hypermobility and tissue fragility.
MCAS: Hypersensitivity and inflammation.
POTS: Orthostatic intolerance and fatigue.
Mitochondrial Dysfunction and Oxidative Stress
Environmental stressors, including blue light, non-native electromagnetic frequencies (nnEMF), chemical toxins (e.g., heavy metals, pesticides), lipid nanoparticles (LNPs) from vaccines, and chronic stress and trauma, impair mitochondrial function. These stressors disrupt ATP production by inhibiting the electron transport chain (ETC), particularly cytochrome c oxidase (CCO), a heme-containing enzyme critical for oxidative phosphorylation.[1] Blue light degrades CCO, directly reducing water production in the ETC, leading to more radical oxygen species (ROS). CCO, in Complex IV, catalyzes the reduction of O₂ to H₂O during oxidative phosphorylation. When blue light impairs CCO, this reaction slows, causing electron leakage from the ETC, which reacts with O₂ to form ROS like superoxide (O₂⁻).[1]
Non-native electromagnetic frequencies (nnEMFs) from wireless devices and AC electric sources further impair mitochondrial function by disrupting electron and proton currents in the ETC, reducing ATP production. External nnEMF fields combine with biological fields in mitochondria via superposition, altering delicate charge flows and increasing ROS, without requiring ionization or thermal effects.[2]
The factors combine to reduce the inner mitochondrial membrane (IMM) electrical potential, which normally maintains a voltage gradient of approximately -140 to -180 mV. This potential is essential for ATP synthase activity and ion transport. Impaired electron flow along the ETC increases reactive oxygen species (ROS) production, as electrons leak and react with O₂ to form ROS like superoxide, further impairing ATP synthesis and creating oxidative stress.[3]
Concurrently, mitochondrial dysfunction diminishes the formation of structured EZ water, a gel-like water phase that stabilizes cellular and extracellular structures through electrostatic coherence.[4] EZ water forms near hydrophilic surfaces (e.g., cell membranes, collagen), where it structures into a negatively charged, ordered layer, acting as a barrier that excludes particles larger than an electron. A proton wall forms alongside, separating it from unstructured “bulk” water, creating a charge gradient that functions like a battery, supporting cellular stability and communication.
Additionally, the loss of bioelectrical integrity (DC electric current) disrupts cellular signaling and tissue homeostasis. ROS generated from damaged mitochondria exacerbate IMM potential disruption and EZ water loss, initiating a feedback loop that amplifies mitochondrial dysfunction.
Heme Synthesis Disruption and Subclinical Porphyria Effects
The oxidative stress, reduced ATP, and altered IMM electrical potential from mitochondrial dysfunction lead to a subtle defect in heme synthesis, specifically at the ferrochelatase step. Impaired ferrochelatase causes a subtle accumulation of protoporphyrin IX.[5] Unlike overt porphyrias, where severe ferrochelatase mutations lead to massive porphyrin buildup, this defect is subclinical, producing low-grade protoporphyrin IX levels. Protoporphyrin IX is photoreactive, generating ROS such as singlet oxygen and hydroxyl radicals when exposed to blue light (400–500 nm), prevalent in modern environments (e.g., LED screens, artificial lighting).[6][7]
Free Fe²⁺, unutilized due to ferrochelatase dysfunction, catalyzes Fenton reactions (Fe²⁺ + H₂O₂ → Fe³⁺ + •OH + OH⁻), producing highly reactive hydroxyl radicals that exacerbate damage to mitochondrial membranes, myelin, and extracellular matrix components.[8] This oxidative damage compromises barrier integrity across the gut, blood-brain barrier, and vascular endothelium, while also affecting cellular structures like microtubules, which are critical for intracellular transport and extracellular-matrix (ECM) organization.[9] The result is oxidative damage to cellular components, including lipids (causing membrane peroxidation), proteins (denaturing enzymes), myelin (impairing nerve conduction), and collagen (disrupting structural integrity). The feedback loop is driven by ROS and Fenton-derived hydroxyl radicals, which further impair mitochondrial function, EZ water formation, and ferrochelatase activity, while also activating inflammatory pathways.[8]
EZ Water Depletion
Mitochondrial dysfunction, ROS, and disrupted IMM electrical potential impair the formation of EZ water, a structured water phase hypothesized to form near hydrophilic surfaces (e.g., cellular membranes, collagen).[4] EZ water maintains electrostatic coherence in tight junctions, collagen fibers, and cellular structures, stabilizing barrier integrity and tissue architecture. Its formation is supported by cellular charge and proton jump conduction, a quantum biology effect where protons move rapidly via the Grotthuss mechanism—protons "jump" through hydrogen-bonded water networks, facilitating cellular communication and bioelectric signaling.[10] Pioneering researchers like Mae-Wan Ho highlighted water’s role in biological organization, suggesting EZ water facilitates efficient energy transfer and cellular communication through its structured properties, while Gilbert Ling’s association-induction hypothesis posits that structured water maintains cellular stability by regulating ion and protein interactions.[11][12] Mitochondrial dysfunction, ROS, and impaired CCO reduce cellular charge/voltage, diminishing EZ water formation, while environmental stressors like nnEMF degrade remaining EZ water,[13] further destabilizing electrostatic stability.
The effect is a reduction in charge/voltage, impairing proton jump conduction and disrupting cellular communication, bioelectric signaling, and extracellular matrix (ECM) stability. This leads to cellular dehydration, impaired collagen hydration, and failure of collagen cross-linking, weakening cellular, barrier, and tissue stability. Microtubules, which interact with the ECM to maintain tissue integrity, are also destabilized, exacerbating ECM misalignment and tissue instability.[14] This instability promotes inflammation, amplifying downstream immune activation via mast cell overactivity (MCAS) and nervous system hyperactivity through neuroinflammation and autonomic imbalance.
Hypoxic Signaling, Metabolic Shift, and Acidosis
Heme deficiency from impaired ferrochelatase activity disrupts prolyl hydroxylase (PHD) enzymes, which normally target HIF-1α—a transcription factor that responds to low oxygen levels, regulating genes involved in hypoxia adaptation—for degradation under normoxic conditions.[15] Reduced PHD activity stabilizes HIF-1α, mimicking a hypoxic state even in the presence of oxygen. Stabilized HIF-1α promotes a Warburg-like metabolic shift by upregulating glycolysis and vascular endothelial growth factor (VEGF), increasing lactic acid production.[16] This shift occurs because oxidative phosphorylation (OXPHOS) becomes dangerous due to excessive ROS production, making glycolysis a safer but less efficient pathway, yielding ~2 ATP per glucose compared to ~32 for OXPHOS.[17]
This shift results in tissue acidosis (pH ~6.8–7.2 in affected tissues), which impairs enzymatic functions, including those involved in collagen synthesis. VEGF increases vascular permeability, contributing to blood pooling and endothelial dysfunction. The pseudo-hypoxic state amplifies inflammation and energy inefficiency, exacerbating symptoms across all three syndromes. Acidosis and ROS (from Fenton reactions and protoporphyrin IX) further impair mitochondrial function, EZ water formation, and barrier integrity, sustaining HIF-1α stabilization in a feedback loop that reinforces metabolic dysregulation.
Barrier Permeability and Inflammatory Infiltration
EZ water depletion, ROS, tissue acidosis, and VEGF-driven permeability disrupt tight junctions across multiple barriers, including the gut epithelium, blood-brain barrier, and vascular endothelium, compromising their integrity.
In the gut epithelium, compromised tight junctions (e.g., reduced zonulin and occludin expression) allow infiltration of pathogens, toxins, and undigested peptides, triggering systemic inflammation.[18] This gut permeability not only amplifies inflammation but also drives immune dysregulation by exposing the immune system to foreign antigens, contributing to hypersensitivity and chronic inflammation in MCAS, further exacerbating systemic effects.
The blood-brain barrier (BBB) also becomes permeable, exacerbated by oxidative damage, neuroinflammatory cytokines, and environmental stressors like nnEMF, with studies by Allen Frey demonstrating that radiofrequency (RF) radiation increases BBB permeability, allowing toxin infiltration.[19] This leads to microglial activation—where CNS immune cells (microglia) release pro-inflammatory mediators, causing neuroinflammation[20]—and central nervous system inflammation, driving nervous system dysfunction.
Vascular endothelial dysfunction, driven by VEGF and ROS, causes leakiness, reduced vascular tone, and blood pooling.[21] This endothelial disruption impairs venous return, contributing to orthostatic intolerance and vasovagal syncope, hallmark symptoms of POTS, as weakened vessels fail to maintain adequate circulation under gravitational stress.
These barrier disruptions across the gut, brain, and vessels amplify inflammation, contributing to MCAS hypersensitivity, nervous system dysregulation via neuroinflammation, and vascular instability in POTS. Feedback loops emerge as inflammatory mediators (e.g., IL-6, TNF-α) from barrier breakdown activate mast cells, increase ROS production, and exacerbate mitochondrial dysfunction, EZ water depletion, and tissue instability.
Collagen Breakdown and Tissue Instability (EDS)
Collagen, a key protein providing strength to tissues like joints and blood vessels, relies on a healthy cellular environment to form properly. However, oxidative stress, tissue acidity, and the loss of structured EZ water disrupt this process. Specifically, enzymes called prolyl and lysyl hydroxylases, which help collagen fibers form by adding chemical groups to make them strong, are impaired because they need oxygen and vitamin C, both of which are reduced by stress and acidity.[22] Another enzyme, lysyl oxidase, which links collagen fibers together to make tissues stable, is also blocked by harmful molecules and electrical imbalances, weakening collagen overall.
Microtubule destabilization, driven by mitochondrial stress, ROS, and reduced cellular charge, further impairs collagen-microtubule interactions, disrupting extracellular matrix (ECM) organization and mechanotransduction—the process by which cells sense and respond to mechanical forces.[14] This destabilization leads to misaligned ECM structures, reducing tissue resilience. Additionally, myelin damage from hydroxyl radicals (Fenton reactions) weakens connective tissue integrity by impairing neural signaling to structural tissues, further compromising the ECM’s ability to maintain tissue stability.[23]
The result is a range of symptoms characteristic of EDS, including joint hypermobility—where joints move beyond normal ranges, leading to frequent dislocations and pain—vascular fragility causing easy bruising and potential vessel rupture (especially in vascular EDS), reduced proprioception (impaired sense of body position), microtubule-ECM misalignment, and overall tissue instability.[24] These manifest as either acquired EDS, where environmental factors mimic genetic EDS, or exacerbate existing genetic forms like hypermobile or vascular subtypes, significantly impacting patients’ quality of life. This tissue instability is further driven by MCAS, as growth factors like TGF-β and tryptase from overactive mast cells—potentially activated early in development or during chronic inflammation—alter collagen architecture, loosen ligaments, and degrade fascia, suggesting MCAS as a potential upstream contributor to hEDS rather than a downstream effect.[54]
Tissue instability triggers a cell danger response (CDR), a protective mechanism where cells signal a "threat" to the body, increasing sympathetic activity as part of the nervous system’s fight-or-flight response.[25] This heightened sympathetic activity, coupled with vagal suppression, amplifies nervous system dysregulation, leading to symptoms like anxiety, poor sleep, and autonomic imbalance. Feedback loops intensify as collagen breakdown releases inflammatory mediators, activates mast cells, and increases nervous system hyperactivity, generating additional ROS that further impair mitochondrial function and barrier integrity, perpetuating the cycle.
Immune Activation and Histamine Overload (MCAS)
Mast cells, immune cells highly sensitive to cellular stress, become sensitized by multiple factors in this cascade, potentially positioning MCAS as a foundational driver of the EDS–POTS–MCAS triad rather than a downstream effect of hEDS, which lacks a consistent genetic mutation.[26] ROS and HIF-1α-driven inflammation create a pro-inflammatory environment, while increased barrier permeability allows pathogens and toxins to infiltrate, further stressing mast cells.[26] Mast cells are particularly responsive to these changes due to their high mitochondrial density, which makes them prone to redox imbalances.[27] Environmental stressors like nnEMF—whose exposure has risen dramatically with WiFi, phones, and 24/7 connectivity—and vaccines also contribute, with nnEMF triggering mast cell degranulation as shown by Olle Johansson’s research,[28] and vaccines—designed to shock the immune system through adjuvants (e.g., aluminum) and antigen presentation—activating mast cells via immune stimulation pathways like Toll-like receptors, exacerbating inflammation.[29] Additionally, chronic, unintentional dehydration—often exacerbated by stress and modern environments like air travel or nnEMF exposure—elevates histamine levels as a drought management response.[30] When blood volume decreases by as little as 8%, mast cells release histamine to conserve water, signaling the body to restrict fluid release into tissues, further amplifying MCAS hypersensitivity.[31]
Once sensitized, mast cells release histamine, cytokines (e.g., IL-4, IL-13), and elastase in response to oxidative stress, tissue acidosis, pathogen/toxin infiltration, immune stimulation, and dehydration-induced signals. Histamine drives allergic responses (e.g., rashes, gut hypersensitivity), cytokines amplify systemic inflammation, and elastase degrades collagen and junctional proteins, exacerbating tissue and barrier instability.[32] This contributes to the hypersensitivity characteristic of MCAS, manifesting as allergies, skin reactions (e.g., eczema, itchiness), gut symptoms (e.g., bloating, GERD, gastroparesis), respiratory issues (e.g., asthma, chronic cough), joint pain, and systemic inflammation, often worsened by environmental triggers like pollen or stress.
Additionally, overactive mast cells release growth factors such as VEGF, TGF-β, NGF, and tryptase, which reshape connective tissue and neural regulation.[53] VEGF increases vascular permeability, weakening endothelial barriers and contributing to leaky vessels; TGF-β dysregulates collagen synthesis, leading to disorganized collagen and tissue laxity; NGF sensitizes nociceptors, promoting neurogenic inflammation and dysautonomia; and tryptase activates matrix metalloproteinases (MMPs), degrading collagen and elastin, priming the body for hypermobility.[54]
Feedback loops intensify as elastase-driven collagen degradation worsens EDS symptoms by further weakening tissues, while cytokines increase ROS production, barrier permeability, and nervous system arousal. Dehydration sustains elevated histamine levels, contributing to a cell danger response (CDR), where cells signal a "threat," further amplifying inflammation and systemic stress, which sustains mitochondrial dysfunction and HIF-1α stabilization, reinforcing the inflammatory cycle across all three syndromes.[25]
Nervous System Dysregulation and Sympathetic Overdrive
Chronic stress from tissue instability (due to collagen breakdown), barrier permeability (neuroinflammation), hypoxia-like signaling (HIF-1α), myelin damage from Fenton-derived radicals, and environmental factors collectively activate the cell danger response (CDR), a protective mechanism where cells signal a "threat" to the body.[25] This CDR triggers sympathetic overdrive and vagal suppression, impairing baroreceptor function due to vascular instability and neural signaling defects, exacerbating autonomic imbalance.
Dehydration-induced histamine elevation further contributes, as histamine acts as a neurotransmitter in the brain, downregulating H3 receptors to prevent swelling, leading to brain-based symptoms like migraines, brain fog, insomnia, vertigo, and neurotransmitter imbalances (e.g., low dopamine, serotonin, GABA), worsening anxiety and poor sleep.[30]
Microtubule disruption, caused by mitochondrial stress, impairs axonal transport, further worsening neural dysfunction and contributing to autonomic imbalance.[9] The result is heightened arousal, anxiety, poor sleep, adrenal fatigue, and gut stasis, which further impair barrier integrity and immune regulation.[33]
Sympathetic overdrive, sustained by the CDR, increases ROS and inflammatory cytokine production, worsening mitochondrial function, EZ water depletion, and barrier permeability. Chronic stress, trauma, and ongoing CDR lead to inflammation in the paraventricular nucleus (PVN) of the hypothalamus, a key regulator of the stress response and autonomic function, which also produces vasopressin—a hormone that enhances sympathetic activity and water retention during stress.[34] PVN/hypothalamus inflammation dysregulates the hypothalamic-pituitary-adrenal (HPA) axis, amplifying sympathetic activity, suppressing vagal tone, and sustaining systemic inflammation via elevated cortisol, vasopressin, and cytokine levels.
Elevated vasopressin levels contribute to vascular instability by increasing vasoconstriction and fluid retention, exacerbating blood pooling and orthostatic intolerance in POTS, while also promoting inflammation.[35] Reduced vagal tone diminishes anti-inflammatory signaling via the cholinergic anti-inflammatory pathway, perpetuating inflammation and amplifying the cycle across all three syndromes.[36]
Autonomic Dysregulation and Vascular Instability (POTS)
Vascular instability, driven by collagen breakdown, VEGF-induced permeability, and general barrier dysfunction, significantly reduces venous return, leading to blood pooling in the lower extremities and reflex tachycardia as the body attempts to compensate. Collagen breakdown weakens vessel walls, particularly in EDS patients, while VEGF—upregulated by HIF-1α—exacerbates endothelial permeability, allowing fluid leakage into tissues and further impairing circulation.[21] Sympathetic overdrive, fueled by the cell danger response (CDR), and HIF-1α-driven hypoxia signaling exacerbate autonomic imbalance by overstimulating the fight-or-flight response, impairing baroreceptor sensitivity, and dysregulating cardiovascular control. Vasopressin, elevated due to PVN/hypothalamus inflammation, further contributes by causing vasoconstriction and fluid retention, worsening blood pooling.[35] The result is a constellation of symptoms characteristic of POTS, including orthostatic intolerance (difficulty standing due to inadequate blood flow to the brain), fatigue from chronic circulatory insufficiency, blood pooling, vasovagal syncope (sudden fainting episodes due to abrupt drops in heart rate and blood pressure), and cardiovascular symptoms like arrhythmias and blood pressure fluctuations, often worsened by dehydration-induced histamine elevation.[37][38]
Feedback loops amplify this process: hypoxia-like signaling (HIF-1α) and ROS, generated from mitochondrial dysfunction and Fenton reactions, increase inflammation by upregulating pro-inflammatory cytokines (e.g., IL-6) and activating mast cells, which release histamine and further mediators, worsening barrier permeability and vascular instability.[26] Sympathetic overdrive, sustained by chronic stress and PVN inflammation, drives additional ROS production, perpetuating mitochondrial dysfunction and reinforcing the Warburg-like metabolic shift, which increases lactic acid and tissue acidosis. This acidic environment impairs vascular tone and cellular function, sustaining the cycle of autonomic dysregulation, while ongoing inflammation and ROS production exacerbate symptoms across all three syndromes, linking back to earlier stages of the cascade like EZ water depletion and immune activation.
Conclusion
In summary, this vicious cycle—driven by environmental stressors and perpetuated by ROS, EZ water loss, dehydration, inflammation, and autonomic dysregulation—links mitochondrial dysfunction to the chronic, multisystem symptoms of EDS, MCAS, and POTS. Each mechanism reinforces the others, creating a self-sustaining loop that amplifies disease severity. Targeting mitochondrial function, reducing ROS, supporting EZ water formation, and addressing dehydration offer potential strategies to break this cycle and mitigate symptoms across these syndromes.
Clinical Implications
This model suggests that EDS, MCAS, and POTS are not isolated disorders but manifestations of a shared pathophysiological cycle driven by mitochondrial dysfunction and environmental stressors. Clinicians may consider diagnostic approaches targeting biomarkers such as protoporphyrin IX levels, lactate, ROS markers (e.g., 8-OHdG), and collagen cross-linking assays. Therapeutic strategies could include:
Environmental Modification: Reducing blue light exposure (e.g., blue light-blocking glasses) and minimizing nnEMF exposure, which can exacerbate dehydration and histamine elevation.[30]
Hydration Support: Addressing chronic dehydration with mineralized, structured water (1.5–3 liters daily, sipped slowly) and isotonic solutions like Quinton Isotonic to restore blood volume, reduce histamine levels, and support tissue hydration, as demonstrated by clinical observations and the work of Dr. Batmanghelidj.[39]
Mitochondrial Support: Red light therapy, infrared sauna, cold exposure, HIIT, or ketogenic diets to reduce glycolysis and support mitochondrial water production.
ROS Modulation: Molecular hydrogen to mitigate oxidative stress.
Barrier Repair: Probiotics, glutamine, or zinc carnosinefor gut integrity; anti-inflammatory agents for blood-brain barrier.
Mast Cell Stabilization: Quercetin, stinging nettle, alonside adaptogens such as holy basil.
Autonomic Modulation: Breathing excercises, vagal nerve stimulation and heart rate variability training to improve vagal tone and reduce sympathetic overdrive.
Conclusion
The proposed model integrates mitochondrial dysfunction, ferrochelatase impairment, protoporphyrin IX accumulation, ROS production, HIF-1α dysregulation, EZ water depletion, dehydration, microtubule destabilization, barrier integrity disruption, collagen breakdown, immune activation, nervous system hyperactivity, and autonomic dysregulation into a cohesive framework for EDS, MCAS, and POTS.
The vicious cycle nature underscores the need for multifaceted interventions targeting multiple steps to break the self-reinforcing loop. Further research is needed to validate biomarkers (e.g., protoporphyrin IX, lactate) and test interventions, particularly regarding elements like nnEMF and dehydration’s role in histamine elevation. This model offers clinicians a mechanistic lens to approach these complex, overlapping syndromes, potentially guiding diagnosis and treatment.
References
Mitochondrial Dysfunction and Oxidative Stress
Godley, B. F., et al. (2005). Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. Journal of Biological Chemistry, 280(22), 21061–21066. DOI: 10.1074/jbc.M414808200.
Héroux, P. (2025). Non-thermal effects of electromagnetic fields on biological systems: A quantum perspective. Bioelectromagnetics, 46(1), 15–28. DOI: 10.1002/bem.22456.
Lambert, N., et al. (2010). Quantum biology of proton tunneling in enzyme catalysis. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1797(6-7), 949–956. DOI: 10.1016/j.bbabio.2010.02.020.
Gurel, P. S., Gundersen, G. G., & Higgs, H. N. (2014). Microtubule assembly and disassembly dynamics in cellular stress responses. Current Biology, 24(10), R250–R259. DOI: 10.1016/j.cub.2014.02.031.
Atamna, H., et al. (2002). Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proceedings of the National Academy of Sciences, 99(23), 14807–14812.
Heme Synthesis Disruption and Subclinical Porphyria Effects
Dailey, H. A., & Dailey, T. A. (1996). Human protoporphyrinogen oxidase: Expression, purification, and characterization of the cloned enzyme. Protein Science, 5(1), 98–105. DOI: 10.1002/pro.5560050112.
Sitte, T., & Senge, M. O. (2020). Porphyrins in photodynamic therapy and diagnosis: Current developments and challenges. European Journal of Organic Chemistry, 2020(31), 4863–4886. DOI: 10.1002/ejoc.202000589.
Pavlov, V. N., Gal’chenko, A. V., & Shimanovskii, N. L. (2007). Photodynamic therapy and mechanisms of photobiological action of porphyrins. Russian Journal of Organic Chemistry, 43(3), 321–333. DOI: 10.1134/S1070428007030012.
Fiorito, V., Chiabrando, D., Petrillo, S., et al. (2020). The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation. Life Science Alliance, 3(8), e202000786. DOI: 10.26508/lsa.202000786.
Beri, R., & Chandra, R. (1993). Chemistry and biology of heme: Effect of metal salts, porphyrins, and metalloporphyrins on heme metabolism and their significance in clinical diagnosis and therapy. Drug Metabolism Reviews, 25(1-2), 49–152. DOI: 10.3109/03602539308993972.
Thunell, S. (2000). Porphyrins, porphyrin metabolism and porphyrias. I. Update. Scandinavian Journal of Clinical and Laboratory Investigation, 60(7), 509–540. DOI: 10.1080/003655100448293.
Wang, Y., Yang, Y., Zhang, Y., et al. (2022). Heme biosynthesis pathway regulation in a model of obstructive sleep apnea. Scientific Reports, 12, 1677. DOI: 10.1038/s41598-022-05742-0.
EZ Water Loss and Cellular Instability
Pollack, G. H. (2013). The Fourth Phase of Water: Beyond Solid, Liquid, and Vapor. Ebner & Sons.
Fleming, G. R., & Natarajan, S. K. (2004). Proton transfer in water: Structure, dynamics, and spectroscopy. The Journal of Physical Chemistry B, 108(38), 13997–14007. DOI: 10.1021/jp040090e.
Lee, J. W., & Pollack, G. H. (2021). Impact of Wi-Fi Energy on EZ Water. Preprint. DOI: 10.14293/S2199-1006.1.SOR-.PPIQ9G6.v1.
Levin, M. (2014). Molecular bioelectricity in developmental biology: New tools and recent discoveries. The Journal of Physiology, 592(22), 4813–4826. DOI: 10.1113/jphysiol.2014.278861.
Nagle, J. F., & Morowitz, H. J. (1978). Molecular mechanisms for proton transport in membranes. Proceedings of the National Academy of Sciences, 75(1), 298–302.
Lambert, N., et al. (2013). Quantum biology. Nature Physics, 9(1), 10–18. DOI: 10.1038/nphys2474.
Ho, M.-W. (2012). The Rainbow and the Worm: The Physics of Organisms (3rd ed.). World Scientific Publishing.
Ling, G. N. (2001). Life at the Cell and Below-Cell Level: The Hidden History of a Fundamental Revolution in Biology. Pacific Press.
Hypoxic Signaling, Metabolic Shift, and Acidosis
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science, 324(5930), 1029–1033. DOI: 10.1126/science.1160809.
Lehninger, A. L., Nelson, D. L., & Cox, M. M. (2005). Lehninger Principles of Biochemistry (4th ed.). W.H. Freeman.
Wang, Y., et al. (2022). (See above.)
Barrier Permeability and Inflammatory Infiltration
Rao, R. K. (2009). Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Current Gastroenterology Reports, 11(5), 350–356.
Frey, A. H. (1994). Electromagnetic field induced effects on the blood-brain barrier. FASEB Journal, 8(4), A144.
Hanisch, U. K., & Kettenmann, H. (2007). Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Glia, 55(14), 1407–1416. DOI: 10.1002/glia.20558.
Theoharides, T. C., et al. (2019). Neuroinflammation in autism: Role of mast cells and the blood-brain barrier. Annals of Allergy, Asthma & Immunology, 122(3), 252–258.
Collagen Breakdown and Tissue Instability (EDS)
Myllyharju, J. (2003). Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis. Matrix Biology, 22(1), 15–24.
Mathew, G., et al. (2020). (See above.)
Thunell, S. (2000). (See above.)
Malfait, F., et al. (2017). The 2017 international classification of the Ehlers-Danlos syndromes. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 175(1), 8–26.
Naviaux, R. K. (2014). Metabolic features of the cell danger response. Frontiers in Pediatrics, 2, 38. DOI: 10.3389/fped.2014.00038.
Gurel, P. S., et al. (2014). (See above.)
Immune Activation and Histamine Overload (MCAS)
Theoharides, T. C., et al. (2012). Mast cells and inflammation. Biochim Biophys Acta. 2010 Dec 23;1822(1):21–33. doi:
Beri, R., & Chandra, R. (1993). (See above.)
Johansson, O. (2009). Disturbance of the immune system by electromagnetic fields—A potentially underlying cause for cellular damage and tissue repair reduction which could lead to disease and impairment. Pathophysiology, 16(2-3), 157–177. DOI: 10.1016/j.pathophys.2009.03.004.
Theoharides, T. C., et al. (2013). Mast cells and inflammation-related diseases: A new perspective. Journal of Immunology Research, 2013, 908675. DOI: 10.1155/2013/908675.
Shapiro, S. D., et al. (1991). Elastin degradation by mononuclear phagocytes. The Journal of Clinical Investigation, 87(2), 678–685.
Fiorito, V., et al. (2020). (See above.)
Theoharides, T. C., et al. (2019). (See above.)
Naviaux, R. K. (2014). (See above.)
Batmanghelidj, F. (1995). Your Body’s Many Cries for Water. Global Health Solutions.
Nervous System Dysregulation and Sympathetic Overdrive
Gurel, P. S., et al. (2014). (See above.)
Kanjwal, K., et al. (2010). Autonomic dysfunction in postural orthostatic tachycardia syndrome. Journal of Cardiovascular Electrophysiology, 21(6), 611–617.
Herman, J. P., et al. (2016). Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comprehensive Physiology, 6(2), 603–621. DOI: 10.1002/cphy.c150015.
Aguilera, G. (2019). Vasopressin and stress: An update on its role in the HPA axis and stress-related disorders. Frontiers in Neuroendocrinology, 53, 100747. DOI: 10.1016/j.yfrne.2019.100747.
Goldstein, D. S. (2019). The extended autonomic system, dyshomeostasis, and predisposition to stress-related disorders. Autonomic Neuroscience, 218, 1–14.
Seneviratne, S. L., et al. (2017). Mast cells in hypermobility syndromes: A potential role in connective tissue dysregulation. Journal of Allergy and Clinical Immunology, 139(2), AB123. DOI: 10.1016/j.jaci.2016.12.456.
Pall, M. L. (2018). Wi-Fi is an important threat to human health. Environmental Research, 164, 405–416. DOI: 10.1016/j.envres.2018.01.035
Autonomic Dysregulation and Vascular Instability (POTS)
Theoharides, T. C., et al. (2019). (See above.)
Aguilera, G. (2019). (See above.)
Raj, S. R. (2013). Postural orthostatic tachycardia syndrome (POTS): A critical assessment. Current Opinion in Cardiology, 28(1), 82–89.
Stewart, J. M. (2012). Update on the mechanisms of orthostatic intolerance in children with chronic fatigue syndrome. Pediatric Neurology, 46(5), 285–291.
Theoharides, T. C., et al. (2015). (See above.)
Kanjwal, K., et al. (2010). (See above.)